Same Indication

Digoxin vs Upadacitinib

Digoxin vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Digoxin and Upadacitinib.

Mechanism of Action

Digoxin: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Digoxin — 36-48 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Digoxin — C41H64O14; Upadacitinib — C17H19F3N6O.

Molecular Weight: Digoxin — 780.9430 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Digoxin — Small molecule; Upadacitinib — Small molecule.